From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery

被引:795
作者
Banks, William A. [1 ,2 ]
机构
[1] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, 1660 S Columbian Way, Seattle, WA 98108 USA
[2] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, 1660 S Columbian Way, Seattle, WA 98108 USA
关键词
AMYLOID-BETA-PROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; RECEPTOR-RELATED PROTEIN-1; MOUSE CEREBRAL PERICYTES; NECROSIS-FACTOR-ALPHA; SPINAL-CORD BARRIER; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; ENDOTHELIAL-CELLS; P-GLYCOPROTEIN;
D O I
10.1038/nrd.2015.21
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
One of the biggest challenges in the development of therapeutics for central nervous system (CNS) disorders is achieving sufficient blood-brain barrier (BBB) penetration. Research in the past few decades has revealed that the BBB is not only a substantial barrier for drug delivery to the CNS but also a complex, dynamic interface that adapts to the needs of the CNS, responds to physiological changes, and is affected by and can even promote disease. This complexity confounds simple strategies for drug delivery to the CNS, but provides a wealth of opportunities and approaches for drug development. Here, I review some of the most important areas that have recently redefined the BBB and discuss how they can be applied to the development of CNS therapeutics.
引用
收藏
页码:275 / +
页数:18
相关论文
共 175 条
[11]   Enhanced leptin transport across the blood-brain barrier by α1-adrenergic agents [J].
Banks, WA .
BRAIN RESEARCH, 2001, 899 (1-2) :209-217
[12]   PEPTIDES AND THE BLOOD-BRAIN-BARRIER - LIPOPHILICITY AS A PREDICTOR OF PERMEABILITY [J].
BANKS, WA ;
KASTIN, AJ .
BRAIN RESEARCH BULLETIN, 1985, 15 (03) :287-292
[13]   HIV-1 protein gp120 crosses the blood-brain barrier: Role of adsorptive endocytosis [J].
Banks, WA ;
Kastin, AJ ;
Akerstrom, V .
LIFE SCIENCES, 1997, 61 (09) :PL119-PL125
[14]   Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood-brain barrier [J].
Banks, William A. ;
Burney, Basil O. ;
Robinson, Sandra M. .
PEPTIDES, 2008, 29 (11) :2061-2065
[15]   Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: An age-related selective uptake with reversal of learning impairment [J].
Banks, William A. ;
Farr, Susan A. ;
Morley, John E. ;
Wolf, Kathy M. ;
Geylis, Valeria ;
Steinitz, Michael .
EXPERIMENTAL NEUROLOGY, 2007, 206 (02) :248-256
[16]   Impairments in Brain-to-Blood Transport of Amyloid-β and Reabsorption of Cerebrospinal Fluid in an Animal Model of Alzheimer's Disease are Reversed by Antisense Directed Against Amyloid-β Protein Precursor [J].
Banks, William A. ;
Kumar, Vijaya B. ;
Farr, Susan A. ;
Nakaoke, Ryota ;
Robinson, Sandra M. ;
Morley, John E. .
JOURNAL OF ALZHEIMERS DISEASE, 2011, 23 (04) :599-605
[17]   Minimal penetration of lipopolysaccharide across the murine blood-brain barrier [J].
Banks, William A. ;
Robinson, Sandra M. .
BRAIN BEHAVIOR AND IMMUNITY, 2010, 24 (01) :102-109
[18]   Cell-mediated drug delivery [J].
Batrakova, Elena V. ;
Gendelman, Howard E. ;
Kabanov, Alexander V. .
EXPERT OPINION ON DRUG DELIVERY, 2011, 8 (04) :415-433
[19]   Tumor necrosis factor α and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier [J].
Bauer, Bjorn ;
Hartz, Anika M. S. ;
Miller, David S. .
MOLECULAR PHARMACOLOGY, 2007, 71 (03) :667-675
[20]   eNOS gene deletion restores blood-brain barrier integrity and attenuates neurodegeneration in the thiamine-deficient mouse brain [J].
Beauchesne, Elizabeth ;
Desjardins, Paul ;
Hazell, Alan S. ;
Butterworth, Roger F. .
JOURNAL OF NEUROCHEMISTRY, 2009, 111 (02) :452-459